More news on this day
UK travellers are being urged to think twice before taking sleeping tablets on long flights, as fresh guidance from National Health Service (NHS) trusts and other official materials links sedative use in the air with a higher risk of dangerous blood clots.
Get the latest news straight to your inbox!

Updated UK Advice Connects Sedatives and Flight-Related Clots
Recent travel and thrombosis leaflets from several NHS trusts in the United Kingdom now explicitly advise passengers to avoid taking sleeping tablets on long journeys, including long haul flights, because of their potential to increase the risk of deep vein thrombosis (DVT). These materials sit alongside broader public information that already recognises long distance travel of more than four hours as a risk factor for blood clots in the legs and lungs.
General NHS information on DVT notes that long journeys by plane, car or train can contribute to clot formation, particularly when travellers remain seated for extended periods with limited movement. The condition is considered serious because a clot can travel to the lungs and cause a pulmonary embolism, a medical emergency that can be fatal if not treated promptly.
While DVT following air travel remains relatively uncommon, health information sites across multiple NHS organisations emphasise that certain behaviours can raise the risk further. These include remaining immobile for long stretches, dehydration and the use of substances that encourage prolonged, very still sleep, such as some sedative medications and alcohol.
How Sleeping Pills May Increase Risk at 35,000 Feet
Travel medicine leaflets from UK hospitals and NHS-linked practices describe a particular concern with sedative drugs used either for fear of flying or to promote sleep during long flights. Guidance notes from thrombosis services and travel-risk clinics point out that these medicines can induce an unnaturally deep, non-REM-dominant sleep in which passengers are less likely to shift position or get up to walk.
Several NHS patient information documents on travelling and thrombosis now include specific advice to avoid sleeping tablets on long journeys. The rationale given is that these drugs can lead to longer periods of immobilisation, precisely the situation that encourages blood to pool in the legs. When blood flow slows in the deep veins of the calves or thighs, the chance of a clot forming increases, especially in people with additional risk factors.
Some primary care policies published online by UK surgeries also highlight that sedative medications used to manage flight anxiety can have short term effects on memory, coordination and reaction times. Combined with cabin conditions and restricted space, this may further discourage movement around the aircraft cabin. These local policies report that updated recommendations on both safety and clot risk underpin a shift away from prescribing such drugs purely for air travel.
What Travellers Are Being Advised to Do Instead
Across the UK, public-facing thrombosis and travel leaflets offer a consistent set of alternatives for passengers worried about sleep and comfort on long flights. The most frequently highlighted measures include staying hydrated with water, avoiding excessive alcohol, wearing loose clothing and getting up to walk around the cabin when it is safe to do so. Leg and ankle exercises in the seat are also promoted as a practical way to keep blood flowing.
For people at higher baseline risk of blood clots, such as those with a history of DVT or pulmonary embolism, some NHS hospital trusts recommend discussing travel plans with a clinician well in advance. In certain circumstances, information leaflets indicate that healthcare teams may consider additional preventive strategies, such as compression stockings or pre-flight anticoagulant injections, particularly for long haul journeys between continents.
NHS travel health pages further remind passengers that DVT risk is influenced by a combination of factors, including recent surgery or hospital stays, pregnancy, hormone therapy and some medical conditions. Public guidance suggests that travellers who fall into these higher risk categories should seek personalised advice before long journeys and should make a specific point of asking about clot prevention when planning multiple or very long flights.
Implications for Airlines and Frequent Flyers
The strengthened language in UK health materials on avoiding sleeping tablets during long distance travel may have implications for regular long haul passengers and the airlines that carry them. While there is no blanket ban on sedatives for air travellers, publicly available NHS information, as well as policy statements from some GP practices, indicate a clear trend toward discouraging routine use of these medicines solely for flights.
Airlines already commonly provide generic movement and hydration advice in their in-flight safety literature, reflecting long-standing evidence that prolonged sitting can contribute to clot risk. The emerging emphasis in UK health guidance on avoiding sleeping pills aligns with this broader preventive message and may shape future on-board wellness campaigns, particularly on routes exceeding four hours.
For frequent flyers, especially those combining long haul business trips with other risk factors, the evolving recommendations are a reminder to view sleep management as part of an overall travel health strategy. Public sources suggest a growing preference for non-pharmacological approaches to jet lag and in-flight rest, such as adjusting sleep schedules before departure, using eye masks and earplugs, and planning strategic movement breaks instead of relying on sedative medications.
Navigating Confusing Advice Before Your Next Flight
Conflicting information online about the safety of sleeping pills on planes can leave travellers uncertain. UK-based passengers are increasingly directed toward NHS-backed advice pages and thrombosis charity resources, which tend to emphasise simple, movement-focused preventive steps and caution against any substance that promotes very still sleep in cramped conditions.
Public information also stresses that anyone considering medication for insomnia or fear of flying should discuss it with a healthcare professional as part of routine care, rather than seeking last-minute prescriptions specifically for a single journey. For some people with pre-existing sleep disorders or mental health conditions, sedatives may still be part of a broader treatment plan, but travel-health materials suggest that their use should be carefully reviewed before long flights.
For now, the message emerging from UK health sources is that keeping legs moving, staying hydrated and avoiding sleeping tablets and heavy alcohol use provide a safer route to arriving rested. Travellers planning long haul trips in the coming months may wish to factor this into their seat choices, itinerary planning and conversations with their usual clinicians, particularly if they have any history of blood clots or other risk factors.
Sources: NHS: Deep vein thrombosis (DVT); Cambridge University Hospitals: Travelling and thrombosis risk; Northern Care Alliance: Reducing the risk of a blood clot; University Hospitals Sussex: Advice after venous thromboembolism; United Lincolnshire Hospitals: VTE and long distance travel leaflet